PPARγ modulator-1
Anticancer agent 183 (example 48) is a non-agonistic PPARG modulator. Anticancer agent 183 has a high affinity to PPARG (PPARγ) . Anticancer agent 183 inhibits kinase-mediated phosphorylation of PPARG. Anticancer agent 183 can used for research on metabolic diseases to avoid side effects[1].
Product Specifications
CAS Number
1415321-54-8
UNSPSC
12352005
Target
PPAR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pparγ-modulator-1.html
Solubility
10 mM in DMSO
Smiles
C[C@@H](C1=CC=C(C=C1)C(C)(C)C)NC(C2=CC=C(C(C(C)=C3C)=C2)N3CC4=CC(OC(C)(C)C(O)=O)=CC=C4)=O
Molecular Formula
C34H40N2O4
Molecular Weight
540.69
References & Citations
[1]Theodore Mark Kamenecka, et al. N-benzylindole modulators of pparg. 2012.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PPARγ
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
